{
    "nct_id": "NCT04649112",
    "official_title": "A Phase 1 Study of PBCAR19B in Participants With CD19-expressing Malignancies",
    "inclusion_criteria": "* Relapsed or refractory CD19+ expressing malignancies\n* At least 2 prior regimens per Standard of Care\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* No history of active CNS involvement",
    "miscellaneous_criteria": ""
}